This study evaluated the impact of different durations of post-surgery chemotherapy in the treatment of locally advanced (spread to the lymph nodes) rectal cancer patients.

Researchers suggested that longer post-surgery chemotherapy for stage 3 patients was associated with lower metastasis (spread to other parts of the body) rates and longer disease-free survival.

The aim of this study was to compare health-related quality of life in healthy individuals and patients with rectal cancer.

This study examined whether radical surgery is a suitable follow-up approach to local excision if features indicating poor outcome are identified.

This study compared disease free survival (the time period between the end of treatment and until the disease returns or the patient relapses) for colon cancer patients with a history of smoking versus non-smokers.

This study examined the association between CIMP positive colorectal cancer and patient outcome.

This study reviewed therapies under development for the treatment of a rare form of colorectal cancer. It was found that the combination of 2 or more drug types may be the most effective treatment regime. 

This study investigated the prognostic differences between right-sided tumors (RT) and left-sided tumors (LT) in colon cancer patients. Researchers reported that RT have worse prognosis and survival than LT.

This study investigated the side effect profiles of different PD-1/PD-L1 inhibitor-based combination therapies. The data showed that PD-1/PD-L1 inhibitors in combination with chemotherapy were associated with a higher risk of treatment-related side effects than with targeted therapy or immunotherapy combinations.

This study looked at the amount of fat found around the internal organs – called visceral fat – of colon cancer patients and whether the amount of fat was linked to their survival.

This study investigated the efficacy of a potential prognostic marker for colorectal cancer.